Literature DB >> 35922564

Comparison of short- and long-term adverse kidney outcomes after chimeric antigen receptor T cell therapy and autologous hematopoietic stem cell transplant for diffuse large B cell lymphoma.

Paul Hanna1, Ian Strohbehn1, Daiana Moreno1, Destiny Harden1, Harish Seethapathy1, Shruti Gupta2,3, Meghan Lee1, Tianqi Ouyang1, Matthew Frigault4, Meghan E Sise5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35922564     DOI: 10.1038/s41409-022-01767-7

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.174


× No keyword cloud information.
  6 in total

1.  Chimeric antigen receptor T cells for sustained remissions in leukemia.

Authors:  Shannon L Maude; Noelle Frey; Pamela A Shaw; Richard Aplenc; David M Barrett; Nancy J Bunin; Anne Chew; Vanessa E Gonzalez; Zhaohui Zheng; Simon F Lacey; Yolanda D Mahnke; Jan J Melenhorst; Susan R Rheingold; Angela Shen; David T Teachey; Bruce L Levine; Carl H June; David L Porter; Stephan A Grupp
Journal:  N Engl J Med       Date:  2014-10-16       Impact factor: 91.245

Review 2.  Renal Complications of Hematopoietic-Cell Transplantation.

Authors:  Sangeeta Hingorani
Journal:  N Engl J Med       Date:  2016-06-09       Impact factor: 91.245

3.  Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas.

Authors:  Stephen J Schuster; Jakub Svoboda; Elise A Chong; Sunita D Nasta; Anthony R Mato; Özlem Anak; Jennifer L Brogdon; Iulian Pruteanu-Malinici; Vijay Bhoj; Daniel Landsburg; Mariusz Wasik; Bruce L Levine; Simon F Lacey; Jan J Melenhorst; David L Porter; Carl H June
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

Review 4.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

5.  Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma.

Authors:  Shruti Gupta; Harish Seethapathy; Ian A Strohbehn; Matthew J Frigault; Elizabeth K O'Donnell; Caron A Jacobson; Shveta S Motwani; Samir M Parikh; Gary C Curhan; Kerry L Reynolds; David E Leaf; Meghan E Sise
Journal:  Am J Kidney Dis       Date:  2020-01-20       Impact factor: 8.860

6.  Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery.

Authors:  Victoria Gutgarts; Tania Jain; Junting Zheng; Molly A Maloy; Josel D Ruiz; Martina Pennisi; Edgar A Jaimes; Miguel-Angel Perales; Jaffer Sathick
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-20       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.